NRIX vs TAP
Nurix Therapeutics Inc (NRIX) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
TAP (TAP) common stock.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
TAP does not have a complete income-statement cache yet.
NRIX currently screens at market cap $1.77B. TAP currently screens at market cap $0.
Not investment advice. Open the NRIX and TAP stock pages for the full models.
Not investment advice.